LAG3 antibody (N-Term)
Quick Overview for LAG3 antibody (N-Term) (ABIN2295921)
Target
See all LAG3 AntibodiesReactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Binding Specificity
- N-Term
-
Sequence
- GPPAAAPGHP LAPGPHPAAP SSWGPRPRRY
-
Cross-Reactivity
- Human
-
Cross-Reactivity (Details)
- Calculated cross reactivity: Hu
-
Characteristics
- LAG-3 (Lymphocyte Activation Gene-3, FDC Protein, CD223)
-
Purification
- Purified by Protein A affinity chromatography..
-
Purity
- ~95 % SDS-PAGE
-
Immunogen
- Synthetic peptide corresponding to 30 aa GPPAAAPGHPLAPGPHPAAPSSWGPRPRRY from the first N-terminal D1 domain of human LAG-3 (lymphocyte activation gene-3).
-
Isotype
- IgG1
-
-
-
-
Application Notes
- Optimal working conditions should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Supplied as a liquid in PBS, 0.02 % sodium azide, 10 % glycerol.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- 4 °C,-20 °C
-
Storage Comment
- 4°C (-20°C Glycerol)
-
-
- LAG3 (Lymphocyte-Activation Gene 3 (LAG3))
-
Alternative Name
- LAG-3
-
Pathways
- Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Cancer Immune Checkpoints
Target
-